NEW YORK-- Alkermes PLC said Thursday that it was profitable in its fiscal fourth quarter as it received bigger royalty payments and more revenue for drug manufacturing. Alkermes said it earned $3 million, or 2 cents per share, over the three months ended March 31.» Read More
Federal Reserve Chairman Ben Bernanke is preparing for a most sensitive task: telling jittery investors who have grown accustomed to the U.S. central bank's ultra-easy monetary policies that things will eventually have to change.
What are some of the major seizures and big busts law enforcers have made in recent years? Click on to see 10 cases that were record-breaking, major, or even bizarre in nature.
It was sold legally before the U.S. Food and Drug Administration gained the power to regulate drugs in 1938.. It was widely used to treat weight-loss during World War Two and afterwards, but was eventually banned as an obesity medication by the FDA in 1979..
Emerging markets, and in particular, Latin America will be the drivers for continued growth, Swiss drug maker Roche told CNBC, even as the company faces price pressures elsewhere.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
Research shows how investigators tracing the activities of people who allegedly worked with Julio Chaparro, who pleaded guilty to a money-laundering conspiracy count in May, were able to expose large-scale money laundering at one of the world's biggest banks.
As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry's appetite has been whetted for a fresh surge in business.
Marijn Dekkers, CEO of Bayer, explains to CNBC that while Bayer has felt increased pressure on drug pricing from governments, its success in research and development has the company positioned for success.
Discounts up to 50 percent discount on premium drugs have been passed on to Medicare beneficiaries.
In the border city of Nuevo Laredo, the bodies of nine people were found hanging from a bridge — the result of a turf war between drug cartels. It exposed the Mexican government’s inability to keep the country’s violence level low enough not to scare away tourists and investors.
Scientists at the University of Southern California say they've detected a link between recreational marijuana use and a greater chance among males in their early teens through their mid-30s of contracting a particularly dangerous form of testicular cancer. NBC News reports.
A 74-year old farmer in a small town in southern Germany who had intended to grow sunflowers says he planted more than 1,000 cannabis shrubs by mistake.
Thousands of patients claim marijuana provides them relief from devastating symptoms. We asked High Times Cultivation Editor Danny Danko to put a cost on this relief.
Dr. Leonard Schleifer, Regeneron Pharmaceuticals president/CEO, discusses the strategies behind his company's products, and why people using the same drug are switching to his company versus another.
The marketplace for narcotics isn’t what it used to be. Read ahead to see a list of dangerous drugs that are legal in many American states.
When policy makers in Washington worry about Mexico these days, they think in terms of a handful of numbers: Mexico’s 19,500 hectares devoted to poppy cultivation for heroin; its 17,500 hectares growing cannabis; the 95 percent of American cocaine imports brought by Mexican cartels through Mexico and Central America, the New York Times reports.
In this excerpt from a live interview with CNBC's Michelle Caruso-Cabrera, Grupo Salinas Chairman & CEO Ricardo Salinas says Mexico's new president should try to reduce drug-related violence in Mexico by allowing illegal drugs to flow more freely to the United States buyers who are creating the demand in the first place.
Roger Clemens has been acquitted on all charges by a jury that decided he didn't lie to Congress when he denied using performance-enhancing drugs.
Looking to short the euro? You could buy shares of Sanofi, the world’s fourth-largest drug company by sales, because of its limited exposure to Europe.
Two companies have teamed up to market fingerprint-based drug testing to police, prisons, and, they hope, American companies.